RXQ Compounding LLC FDA Inspection Record

FEI 3011509553 · Inspections, Form 483s, warning letters and import refusals

RXQ Compounding LLC is an FDA-inspected facility (FEI 3011509553) located in Albany, OH, US. RegDataLab tracks 2 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Aug 8, 2017: Official Action Indicated (OAI)
Inspections on record
2 (2 OAI)
Last OAI inspection
Aug 8, 2017
Warning letters
1 listed by FDA for this FEI, latest May 19, 2016
Form 483 and inspection documents
3 in FDA's reading room
Recalls as the recalling firm
3, latest Jun 19, 2019

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Aug 8, 2017Official Action Indicated (OAI)Inadequate number of personnel (21 CFR 211.25(c))
SOPs not followed / documented (21 CFR 211.100(b))
Environmental Monitoring System (21 CFR 211.42(c)(10)(iv))
Cleaning System (21 CFR 211.42(c)(10)(v))
and 5 more
Sep 21, 2015Official Action Indicated (OAI)Clothing appropriate for duties performed (21 CFR 211.28(a))
Air Supply (21 CFR 211.42(c)(10)(iii))
Environmental Monitoring System (21 CFR 211.42(c)(10)(iv))
Validation lacking for sterile drug products (21 CFR 211.113(b))
and 5 more

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Jun 19, 2019Class IID-1634-2019Ascorbic Acid 500 MG/ML (Non-Corn) Injection (PFV), 50 mL per vial, RXQ Compounding, 340… and 85 more products
Crystallization
Sep 25, 2018Class IID-0130-2019Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340…
Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.
Sep 25, 2017Class IID-0012-2018methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding…
Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.

Form 483s and inspection documents

  • 483 on FDA.gov
    Inspection May 6, 2019 to Jun 6, 2019 (dates printed on the document). FDA listing date Jun 6, 2019. Published by FDA Nov 27, 2019.
  • 483 on FDA.gov
    Inspection Jul 11, 2017 to Aug 8, 2017, issued Aug 8, 2017 (dates printed on the document). FDA listing date Oct 25, 2017. Published by FDA Jan 18, 2024.
  • 483 on FDA.gov
    Inspection Aug 24, 2015 to Sep 21, 2015 (dates printed on the document). FDA listing date Nov 8, 2015. Published by FDA Jan 18, 2024.

FDA record score

11 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 22, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

6 records behind this number
RecordDatePoints x age weightAdds
Inspection classified OAIAug 8, 201730 x 0.257.5
Class II recall D-1634-2019, this FEI as the recalling firmJun 19, 20194 x 0.251
Class II recall D-0130-2019, this FEI as the recalling firmSep 25, 20184 x 0.251
Class II recall D-0012-2018, this FEI as the recalling firmSep 25, 20174 x 0.251
Warning letter on FDA's dashboard, which does not show close-outsMay 19, 201610 years or older, so it adds no points0
Inspection classified OAISep 21, 201510 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 22, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 22, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 22, 2026Newest record Nov 13, 2026Current
Warning letter textNov 22, 2026Newest record Nov 17, 2026Current
Recalls (Enforcement Report)Nov 22, 2026Newest record Nov 18, 2026Current
Form 483s and inspection documentsNov 18, 2026Newest record Nov 17, 2026Current
Import refusalsNov 22, 2026Newest record Nov 12, 2026Current

Reviewing RXQ Compounding LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check RXQ Compounding LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
RXQ Compounding LLC
Location
Albany, OH (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.